This assay, which has been used to identify memory CD8+ T cell responses to tumor-derived neoantigens (13–15, 26), uses TCR Vβ sequencing of peptide-stimulated T cell cultures and a bioinformatic pipeline to identify antigen-specific T cell clonotypes. This evidence concerns the gene CD8A and neoplasm.